-
81.发明公开차나무 뿌리 유래 사포닌을 함유하는 계면활성제 및 이를 포함하는 세정제 조성물 审中-实审含有CAMONIA SINENSIS的根提取的含有SAPONIN的表面活性剂和包含其的液体清洁组合物
公开(公告)号：KR1020130035324A
公开(公告)日：2013-04-09
申请号：KR1020110099526
申请日：2011-09-30
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A surfactant containing a saponin extract obtained from the root of camellia sinensis is provided to have an excellent bubble generating function without the stimulation on skin and scalp, and to have excellent cleaning force. CONSTITUTION: A surfactant containing a saponin extract obtained from the root of camellia sinensis comprises saponin. The saponin is triterpenoid saponin. The triterpenoid saponin is one or more compounds selected from chemical formula 1-10. A liquid cleansing composition comprises 0.1-20wt% of the surfactant based on the total weight of the composition. [Reference numerals] (AA) Saponin extract obtained from the root of camellia sinensis R1; (BB) Saponin extract obtained from the root of camellia sinensis R2; (CC) Saponin extract obtained from the root of camellia sinensis R3; (DD) Saponin extract obtained from the root of camellia sinensis R4; (EE) Saponin extract obtained from the root of camellia sinensis R5; (FF) Saponin extract obtained from the root of camellia sinensis R6; (GG) Saponin extract obtained from the root of camellia sinensis R7; (HH) Saponin extract obtained from the root of camellia sinensis R8; (II) Saponin extract obtained from the root of camellia sinensis R9; (JJ) Saponin extract obtained from the root of camellia sinensis R10;
Abstract translation: 目的：提供从山茶根获得的含有皂苷提取物的表面活性剂，具有优异的发泡功能，无需刺激皮肤和头皮，并具有优异的清洁力。 构成：含有从山茶根获得的皂角苷提取物的表面活性剂含有皂苷。 皂苷是三萜皂苷。 三萜皂苷是选自化学式1-10的一种或多种化合物。 基于组合物的总重量，液体清洁组合物包含0.1-20重量％的表面活性剂。 [参考数字]（AA）从山茶根中获得的皂苷提取物; （BB）从山茶根R2获得的皂角苷提取物; （CC）从山茶根中获得的皂角苷提取物; （DD）从山茶根中获得的皂苷提取物R4; （EE）从山茶的根部获得的皂苷提取物R5; （FF）从山茶根R6获得的皂苷提取物; （GG）从山茶根中获得的皂苷提取物R7; （HH）从山茶根中获得的皂角苷提取物R8; （二）从山茶根中获得的皂苷提取物R9; （JJ）从山茶根R10获得的皂苷提取物;
-
公开(公告)号：KR1020110110054A
公开(公告)日：2011-10-06
申请号：KR1020110029587
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/484 , A61K36/48 , A61P25/28 , A61P25/00
CPC classification number: A61K31/35 , A61K31/366 , A61K36/48
Abstract: 본 발명은 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 유효 성분으로 포함하여 지방 세포의 분화를 억제하며, 신체 면역을 증진시키고, 독성 물질을 해독하며, 퇴행성 신경 장애를 예방 또는 개선하는 조성물을 개시한다.
Abstract translation: 本发明涉及一种组合物，其包含作为活性成分的香草雌酚或含有香豆素的豆提取物，其中脂肪细胞分化被抑制，身体的免疫系统得到改善，有毒物质被清除，并且可以预防或改善神经变性疾病。
-
公开(公告)号：KR1020110060140A
公开(公告)日：2011-06-08
申请号：KR1020090116640
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/481 , A61P21/00 , A61P29/00 , A23L1/30
CPC classification number: A61K36/481 , A23L33/105 , A23V2002/00 , A23V2250/21
Abstract: PURPOSE: A composition containing Astragali Radix extract is provided to promote the expression of PGC1-alpha(peroxisome proliferator-activated receptor gamma coactivator 1-alpha). CONSTITUTION: A composition for promoting body energy consumption and muscle metabolism and strengthen muscle contains 1-80 weight% of Astragali Radix extract as an active ingredient. The composition is a pharmaceutical composition or food composition. The Astragali Radix extract is isolated using leaves, stems, and roots of Astragali Radix. The Astragali Radix extract is prepared by extracting Astragali Radix in 10 time volume of distilled water for three hours, filtering with a Whatman No.1 filter, and freeze-drying at -70°C.
Abstract translation: 目的：提供含有黄芪提取物的组合物，以促进PGC1-α（过氧化物酶体增殖物激活受体γ共激活因子1-α）的表达。 构成：用于促进身体能量消耗和肌肉代谢并增强肌肉的组合物含有1-80重量％的黄芪提取物作为活性成分。 组合物是药物组合物或食物组合物。 黄芪提取物使用黄芪的叶，茎和根进行分离。 黄芪提取物通过在10倍体积的蒸馏水中提取黄芪提取物三小时，用Whatman 1号滤器过滤，并在-70℃下冷冻干燥制备。
-
公开(公告)号：KR1020100134381A
公开(公告)日：2010-12-23
申请号：KR1020090052982
申请日：2009-06-15
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for promoting the alcoholysis inside a human body is provided to use a post-heating fermented tea extract as an active ingredient for reducing hangover. CONSTITUTION: A composition for promoting the alcoholysis contains a post-heating fermented tea extract using non-pathogenic microorganisms as an active ingredient. The non-pathogenic microorganisms are selected from the group consisting of yeast, lactobacillus, saccharomyces genus, bacillus genus, and aspergillus genus. The composition promotes the activity of alcohol dehydrogenase and acetaldehyde dehydrogenase.
Abstract translation: 目的：提供一种用于促进人体内醇解的组合物，使用后加热发酵茶提取物作为减少宿醉的活性成分。 构成：用于促进醇解的组合物包含使用非致病微生物作为活性成分的后加热发酵茶提取物。 非病原微生物选自酵母，乳杆菌属，酵母属，芽孢杆菌属和曲霉属。 该组合物促进醇脱氢酶和乙醛脱氢酶的活性。
-
公开(公告)号：KR1020100127728A
公开(公告)日：2010-12-06
申请号：KR1020100049181
申请日：2010-05-26
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/48 , A23L2/52 , A23L33/105 , A61K2236/333 , A23V2200/30
Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.
Abstract translation: 目的：提供含有用低分子量分离的大豆提取物的组合物，以改善血液循环和治疗肥胖症，糖尿病和高脂血症。 构成：用于改善血液循环的组合物含有用1-7％的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇，乙醇，异丙醇，正丙醇，正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。
-
Patent Agency Ranking
公开(公告)号：KR1020100127420A
公开(公告)日：2010-12-06
申请号：KR1020090045858
申请日：2009-05-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/79 , A61K36/896 , A61K36/258
CPC classification number: A61K36/79 , A61K36/258 , A61K36/896 , A61K2300/00
Abstract: PURPOSE: A ginseng complex composition which enhances the bioavailability of saponin is provided to improve the physiological activity of ginseng saponin. CONSTITUTION: A ginseng complex composition for enhancing the bioavailability of saponiin contains Schisandra chinensis extract or Liriope platyphylla extract and ginseng extract containing saponin. The ginseng extract is ginseng fruit extract. The saponin is ginsenoside Re. A composition for enhancing the bioavailability of saponin contains Schisandra chinensis extract or Liriope platyphylla extract as an active ingredient.
Abstract translation: 目的：提高人参皂苷生理活性，提高皂角苷的生物利用度。 构成：提高saponiin生物利用度的人参复合物组合物含有五味子提取物或Liriope platyphylla提取物和含有皂苷的人参提取物。 人参提取物是人参水果提取物。 皂苷是人参皂甙Re。 用于提高皂角苷生物利用度的组合物含有五味子提取物或Liriope platyphylla提取物作为活性成分。
-
公开(公告)号：KR100989834B1
公开(公告)日：2010-10-29
申请号：KR1020060119449
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K31/722 , C08B37/00
CPC classification number: A61K31/722
Abstract: 본 발명은 키토올리고당을 유효성분으로 함유하는 피로 개선용 조성물 및 AMPK 활성 촉진용 조성물에 관한 것으로, 보다 상세하게는 키토올리고당을 함유하여 AMPK 및 지방대사 관련 효소에 영향을 줌으로써 간세포에서의 에너지 대사를 촉진시키는 조성물에 관한 것이다.
키토올리고당, AMPK, 활성, 촉진, 간세포, 에너지대사-
公开(公告)号：KR1020100114349A
公开(公告)日：2010-10-25
申请号：KR1020090032841
申请日：2009-04-15
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/00 , A23L33/105 , A23V2200/302 , A61K36/45 , A61K36/73 , A61K36/87 , A61Q17/04
Abstract: PURPOSE: An antioxidative composition for improving skin condition is provided to enhance antioxidative ability in blood and to treat photoaging by UV ray. CONSTITUTION: An antioxidative composition contains red grape leaf extract, berry mixture and selenium in a weight part of 1:1:1-10:1:1. The berry mixture contains pomegranate, raspberry, blackberry, acai, cranberry, or blueberry. The composition is used for preventing active suppression and used as aging.
Abstract translation: 目的：提供改善皮肤状况的抗氧化组合物，以提高血液中的抗氧化能力，并通过紫外线治疗光老化。 构成：抗氧化组合物含有1：1：1-10：1：1重量份的红葡萄叶提取物，浆果混合物和硒。 浆果混合物含有石榴，覆盆子，黑莓，阿萨伊，蔓越莓或蓝莓。 该组合物用于防止主动抑制并用作老化。
-
公开(公告)号：KR1020100060634A
公开(公告)日：2010-06-07
申请号：KR1020080119311
申请日：2008-11-28
Applicant: (주)아모레퍼시픽
IPC: A61K31/722 , A61P25/28
CPC classification number: A61K31/722
Abstract: PURPOSE: A composition containing chito-oligosaccharide for mitochondria activation is provided to increase mitochondria DNA level and mitochondria-relating enzyme activation and to prevent and treat neurodegenerative diseases or Parkinson' disease. CONSTITUTION: A composition for mitochondria activation contains chito-oligosaccharide as an active ingredient. The chito-oligosaccharide is chito-oligosaccharide lactate. The composition is used for preventing or treating neurodegenerative disease, brain disease, neural disease, heart disease, liver disease, or muscle disease. The composition also used in preventing or treating Parkinson's disease. The composition is a health food composition or pharmaceutical composition. The active ingredient is contained in 10-90 weight% based on total weight.
Abstract translation: 目的：提供含有用于线粒体活化的低聚半乳糖的组合物以增加线粒体DNA水平和线粒体相关酶活化并预防和治疗神经变性疾病或帕金森病。 构成：用于线粒体活化的组合物含有低聚半乳糖作为活性成分。 所述低聚半乳糖是低聚半乳糖。 该组合物用于预防或治疗神经变性疾病，脑疾病，神经疾病，心脏病，肝脏疾病或肌肉疾病。 该组合物还用于预防或治疗帕金森病。 组合物是保健食品组合物或药物组合物。 活性成分的含量为10-90重量％，基于总重量。
-
公开(公告)号：KR1020100048593A
公开(公告)日：2010-05-11
申请号：KR1020080107826
申请日：2008-10-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/48 , A61K36/258 , A61K36/60
CPC classification number: A61K36/258 , A23V2200/32 , A61K36/489 , A61K36/605 , A61K36/808 , A61K36/87
Abstract: PURPOSE: A composition for suppressing enterobacteria of ginseng saponin is provided to inhibit decomposition of ginseng fruit saponin and to enhance bioavailability. CONSTITUTION: A composition for suppressing enterobacteria of ginseng saponin contains Sophora flavescens Aiton, Scrophularia buergeriana, Morus, or ivy extract. The ginseng extract is ginseng fruit extract. The ginseng saponin is ginsenoside Re.
Abstract translation: 目的：抑制人参皂甙肠杆菌的组成，以抑制人参果皂苷的分解，提高生物利用度。 构成：用于抑制人参皂甙肠杆菌的组合物含有苦参皂甙，玄参，桑树或常春藤提取物。 人参提取物是人参水果提取物。 人参皂苷是人参皂苷Re。
-
-
-
-
-
-
-
-
-
Search Results
183
records
(took 0.034 seconds)
